Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Liver, Bladder, Cervical, and Gastric Cancers

(2010) C. M. Sturgeon et al.   CLINICAL CHEMISTRY

Serum fucose level in malignant diseases

(2010) NG Sawke et al.   INDIAN JOURNAL OF CANCER

Structure of a fucose transporter in an outward-open conformation

(2010) Shangyu Dang et al.   NATURE

Delivering nanomedicine to solid tumors

(2010) Rakesh K. Jain et al.   Nature Reviews Clinical Oncology

Treatment of hepatocellular carcinoma by AdAFPep/rep, AdAFPep/p53, and 5-fluorouracil in mice

(2008) Tamotsu Sagawa et al.   HEPATOLOGY

A Phase I Trial of Arterial Infusion Chemotherapy with Gemcitabine and 5-Fluorouracil for Unresectable Advanced Pancreatic Cancer after Vascular Supply Distribution via Superselective Embolization

(2008) K. Miyanishi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Changes in Tumor Vascularity Depicted by Contrast-Enhanced Ultrasonography as a Predictor of Chemotherapeutic Effect in Patients With Unresectable Pancreatic Cancer

(2008) Katsunobu Tawada et al.   PANCREAS